Introducing Kamvas Pro 27 (144Hz): The Industry’s First 27-inch 4K Pen Display with a 144Hz Refresh Rate
LAS VEGAS, Dec. 1, 2025 /PRNewswire/ -- Huion, the industry-leading manufacturer of…
DAHON’s Global Expansion: A Call to Collaborate on New Opportunities
TIANJIN, China, Nov. 27, 2025 /PRNewswire/ -- DAHON, the world's biggest maker…
GigaDevice Launches GD25NX Series xSPI NOR Flash with Dual-Voltage Design
BEIJING--(BUSINESS WIRE)--#Automotive--GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers…
Friendly Fraud Expected to Increase by 25% Between Thanksgiving and Cyber Monday, Warns ACI Worldwide
ACI’s Payments Intelligence approach offers merchants complete journey protection—stopping friendly fraud and…
Jiayin Group Inc. Announces Entry into Loan Facility
SHANGHAI, China, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin”…
Symbiosis Dubai's MBA Class of 2025 Achieves 98% Internship Success in its First Year
Within just one year of its launch, Symbiosis Dubai’s MBA program has…
Bybit Crypto Insights Report: Markets Mixed After October 2025 Rate Cut Amid Uncertainty Over December Decision
DUBAI, UAE, Oct. 31, 2025 /PRNewswire/ --Â Bybit, the world's second-largest cryptocurrency exchange…
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based…
Tirupati, India, Among Asia's Most Affordable Summer Destinations in 2025: Agoda
Digital travel platform Agoda has revealed its list of the most budget-friendly…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…